Analyst Ratings for Endo Pharmaceuticals Holdings Inc (ENDP)

Overall Rating: NEUTRAL Rating Trend:

Avg. $ Target: $36.77 (-5.3%)

Date	Firm	Type	Rating (Past)	PT (Past)	Start $	End $	% Chg.	Details
6/6/2013	Leerink Swann	Upgrade	Outperform (Market Perform)	48.00 (37.00)	35.96	38.82	7.95%	Details
6/6/2013	Cantor Fitzgerald	Downgrade	Sell (Hold)	30.00 (36.00)	35.96	38.82	7.95%	Details
5/16/2013	Buckingham Research	Upgrade	Buy (Neutral)	41.00 (N/A)	33.48	38.82	15.95%	Details
5/13/2013	CRT Capital	Downgrade	Fairly Valued (Buy)	N/A (N/A)	34.97	38.82	11.01%	Details
5/13/2013	William Blair	Downgrade	Market Perform (Outperform)	36.00 (43.00)	34.97	38.82	11.01%	Details
5/13/2013	Lazard Capital	Downgrade	Sell (Neutral)	N/A (N/A)	34.97	38.82	11.01%	Details
5/8/2013	Cowen	Downgrade	Underperform (Neutral)	N/A (N/A)	38.21	38.82	1.6%	Details
4/11/2013	Janney Montgomery Scott	New Coverage	Neutral (N/A)	34.00 (N/A)	34.61	38.82	12.16%	Details
4/10/2013	Standpoint Research	Downgrade	Buy (Hold)	N/A (N/A)	34.98	38.82	10.98%	Details
2/25/2013	Piper Jaffray	Downgrade	Underweight (Neutral)	22.00 (28.00)	28.04	38.82	38.45%	Details
2/7/2013	RBC Capital	Downgrade	Underperform (Sector Perform)	24.00 (25.00)	31.00	38.82	25.23%	Details
1/31/2013	Oppenheimer	Downgrade	Perform (Outperform)	N/A (N/A)	31.66	38.82	22.62%	Details
12/14/2012	Needham & Company » Updated 1/4/2013	Downgrade	Underperform (Hold)	N/A (N/A)	26.65	38.82	45.67%	Details
1/6/2012	ThinkEquity	New Coverage	Buy (N/A)	45.00 (N/A)	34.44	38.82	12.72%	Details
8/15/2011	Collins Stewart	Downgrade	Neutral (N/A)	N/A (N/A)	33.50	38.82	15.88%	Details

Like ENDP Ratings? Also take a look at WPI, WCRX, VRX, TEVA